Spots Global Cancer Trial Database for pexidartinib
Every month we try and update this database with for pexidartinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | NCT03158103 | Gastrointestina... | MEK162 Pexidartinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | NCT03158103 | Gastrointestina... | MEK162 Pexidartinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors | NCT02401815 | Gastrointestina... | PLX9486 Pexidartinib Sunitinib | 18 Years - | Cogent Biosciences, Inc. | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT | NCT04488822 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment | NCT04635111 | Hepatotoxicity Tenosynovial Gi... | TURALIO™ | 18 Years - | Daiichi Sankyo | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT | NCT04488822 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics) | NCT03291288 | Drug Interactio... | Tolbutamide Midazolam Pexidartinib | 18 Years - | Daiichi Sankyo | |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib | NCT04526704 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib | NCT04526704 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT | NCT04488822 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers | NCT02777710 | Colorectal Canc... Pancreatic Canc... Metastatic Canc... Advanced Cancer | Pexidartinib Durvalumab | 18 Years - | Centre Leon Berard | |
| Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) | NCT02371369 | Pigmented Villo... Giant Cell Tumo... Tenosynovial Gi... | Pexidartinib Placebo | 18 Years - | Daiichi Sankyo | |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib | NCT04526704 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib | NCT04526704 | Tenosynovial Gi... | Pexidartinib | 18 Years - | Daiichi Sankyo | |
| Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants | NCT04223635 | Moderate Hepati... | Pexidartinib | 18 Years - 75 Years | Daiichi Sankyo |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
